CONTEXT: Aldosterone production is associated with insulin resistance in obese and hypertensive subjects. However, its effect on insulin sensitivity in healthy subjects is not clear. OBJECTIVE: The objective of this study was to test the hypothesis that increased aldosterone production is associated with lower insulin sensitivity in healthy subjects. DESIGN: This is an analysis of data previously collected during studies conducted as part of the International Hypertensive Pathotype Consortium. PARTICIPANTS AND INTERVENTIONS: Eighty-four subjects free of any medical or psychiatric illness were included in this study. They were studied after 7 d of a standardized high-sodium diet confirmed by 24-h urine sodium above 200 mEq. Insulin sensitivity index (ISI) was calculated after a 75-g oral glucose load with glucose and insulin measurements at 0, 30, 60, and 120 min. Serum aldosterone levels were measured after 45 min of angiotensin II (3 ng/kg/min) infusion. RESULTS: There were significant negative correlations between ISI and age, body mass index (BMI), diastolic blood pressure, and angiotensin II-stimulated aldosterone level (P < 0.01). On multivariate regression analysis, stimulated aldosterone level was an independent predictor of ISI after adjusting for age, BMI, and diastolic blood pressure. Stimulated aldosterone level predicted 8% of the variance in ISI (P = 0.003) with age, BMI, and diastolic blood pressure together predicting 23% of the variance in ISI. Thus, the final regression model predicted 31% of the variance in ISI (P < 0.0001). CONCLUSIONS: Aldosterone production is associated with insulin resistance in normotensive healthy subjects independent of traditional risk factors.
CONTEXT: Aldosterone production is associated with insulin resistance in obese and hypertensive subjects. However, its effect on insulin sensitivity in healthy subjects is not clear. OBJECTIVE: The objective of this study was to test the hypothesis that increased aldosterone production is associated with lower insulin sensitivity in healthy subjects. DESIGN: This is an analysis of data previously collected during studies conducted as part of the International Hypertensive Pathotype Consortium. PARTICIPANTS AND INTERVENTIONS: Eighty-four subjects free of any medical or psychiatric illness were included in this study. They were studied after 7 d of a standardized high-sodium diet confirmed by 24-h urine sodium above 200 mEq. Insulin sensitivity index (ISI) was calculated after a 75-g oral glucose load with glucose and insulin measurements at 0, 30, 60, and 120 min. Serum aldosterone levels were measured after 45 min of angiotensin II (3 ng/kg/min) infusion. RESULTS: There were significant negative correlations between ISI and age, body mass index (BMI), diastolic blood pressure, and angiotensin II-stimulated aldosterone level (P < 0.01). On multivariate regression analysis, stimulated aldosterone level was an independent predictor of ISI after adjusting for age, BMI, and diastolic blood pressure. Stimulated aldosterone level predicted 8% of the variance in ISI (P = 0.003) with age, BMI, and diastolic blood pressure together predicting 23% of the variance in ISI. Thus, the final regression model predicted 31% of the variance in ISI (P < 0.0001). CONCLUSIONS:Aldosterone production is associated with insulin resistance in normotensive healthy subjects independent of traditional risk factors.
Authors: D A García-Estévez; D Araújo-Vilar; G Fiestras-Janeiro; A Saavedra-González; J Cabezas-Cerrato Journal: Horm Metab Res Date: 2003-01 Impact factor: 2.936
Authors: J S Williams; G H Williams; A Raji; X Jeunemaitre; N J Brown; P N Hopkins; P R Conlin Journal: J Hum Hypertens Date: 2006-02 Impact factor: 3.012
Authors: Monika Ehrhart-Bornstein; Karen Arakelyan; Alexander W Krug; Werner A Scherbaum; Stefan R Bornstein Journal: Endocr Res Date: 2004-11 Impact factor: 1.720
Authors: M Ehrhart-Bornstein; V Lamounier-Zepter; A Schraven; J Langenbach; H S Willenberg; A Barthel; H Hauner; S M McCann; W A Scherbaum; S R Bornstein Journal: Proc Natl Acad Sci U S A Date: 2003-11-12 Impact factor: 11.205
Authors: Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla Journal: Am J Physiol Renal Physiol Date: 2016-02-03
Authors: Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella Journal: Curr Hypertens Rep Date: 2016-03 Impact factor: 5.369
Authors: Rajesh Garg; Gordon H Williams; Shelley Hurwitz; Nancy J Brown; Paul N Hopkins; Gail K Adler Journal: Metabolism Date: 2010-10-30 Impact factor: 8.694
Authors: Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams Journal: JCI Insight Date: 2017-12-07